Skip to content
10-K

Annual Report

RESHAPE LIFESCIENCES INC.

0001558370-21-002737

← back to feed
Filed
Mar 11, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Mar 8, 2021 6.17M sh
Operating Cash Flow FY 2020 · Dec 31, 2020 −$8.55M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$14.2M
Long Term Debt FY 2020 · Dec 31, 2020 $9.17M
Long Term Debt FY 2020 · Dec 31, 2019 $2.73M
Cash And Equivalents FY 2020 · Dec 31, 2020 $2.96M
Cash And Equivalents FY 2020 · Dec 31, 2019 $2.94M
Stockholders Equity FY 2020 · Dec 31, 2020 $14.49M
Stockholders Equity FY 2020 · Dec 31, 2019 $24.11M
Stockholders Equity restated FY 2020 · Dec 31, 2018 $31.66M
Current Liabilities FY 2020 · Dec 31, 2020 $11.61M
Current Liabilities FY 2020 · Dec 31, 2019 $10.39M
Total Liabilities FY 2020 · Dec 31, 2020 $22.57M
Total Liabilities FY 2020 · Dec 31, 2019 $15.55M
Current Assets FY 2020 · Dec 31, 2020 $8.94M
Current Assets FY 2020 · Dec 31, 2019 $10.11M
Total Assets FY 2020 · Dec 31, 2020 $37.06M
Total Assets FY 2020 · Dec 31, 2019 $39.66M
Sga Expense FY 2020 · Dec 31, 2020 $4.69M
Sga Expense FY 2020 · Dec 31, 2019 $4.85M
Rd Expense FY 2020 · Dec 31, 2020 $3.5M
Rd Expense FY 2020 · Dec 31, 2019 $3.12M
Net Income FY 2020 · Dec 31, 2020 −$21.63M
Net Income FY 2020 · Dec 31, 2019 −$74.21M
Operating Income FY 2020 · Dec 31, 2020 −$12.46M
Operating Income FY 2020 · Dec 31, 2019 −$24.46M
Gross Profit FY 2020 · Dec 31, 2020 $6.26M
Gross Profit FY 2020 · Dec 31, 2019 $9.31M
Revenue FY 2020 · Dec 31, 2020 $11.3M
Revenue FY 2020 · Dec 31, 2019 $15.09M